Article Details
Retrieved on: 2024-08-05 01:49:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The second trial follows Neuralink's initial human trial in 2023, which demonstrated promising results in restoring motor functions to paralysed ...
Article found on: tickernews.co
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here